Legend:
CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
115 * !
|
Mon, 7/29/2019,
8:30 AM -
10:20 AM
|
CC-201
|
|
Novel Statistical Methods for Emerging Problems in Modern Clinical Trials and Drug Development — Topic Contributed Papers
|
|
Biopharmaceutical Section, International Chinese Statistical Association, Biometrics Section
|
|
Organizer(s): Yuan Ji, The University of Chicago
|
|
Chair(s): Inna Perevozskaya, GSK
|
|
8:35 AM
|
Optimal Selection Procedures and Adaptive Designs for Seamless Phase 2/3 Clinical Trials
Vladimir Dragalin, Janssen R&D
|
|
8:55 AM
|
Master Protocol and Designs for Setting Where Randomized Controlled Trials Are Not Feasible*
Sue-Jane Wang, Center for Drug Evaluation and Research U.S. Food and Drug Administration
|
|
9:15 AM
|
A Unified Framework for Time-To-Toxicity Dose-Finding Designs in Immune and Non-Immune Clinical Trials
Yuan Ji, The University of Chicago; Tianjian Zhou, The University of Chicago
|
|
9:35 AM
|
Bayesian Models for Precision Oncology Clinical Trials
Peter Müller, University of Texas Austin; Yanxun Xu, Johns Hopkins University; Don Berry, MDACC; Apostolia Tsimberidou, MDACC
|
|
9:55 AM
|
Robust Clinical Trial Design and Analysis When Non-Proportional Hazards Are Likely
Keaven Anderson, Merck & Company, Inc.
|
|
10:15 AM
|
Floor Discussion
|
|
